1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > MediPoint: Neurovascular Interventions - Current and Future Players

MediPoint: Neurovascular Interventions - Current and Future Players

Summary

The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices.

The report identifies and analyzes the key companies shaping and driving the Neurovascular Interventions market. The report provides insight into the competitive Neurovascular Interventions landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading doctors, with in-house analysis conducted by GlobalData’s team of industry experts.

Scope

- Investigation of current and future market competition for Neurovascular Interventions
- Competitor assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Neurovascular Interventions in clinical practice.

Reasons to buy

- Gain a high level view of the trends shaping and driving the Neurovascular Interventions market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Table Of Contents

MediPoint: Neurovascular Interventions - Current and Future Players
1 Table of Contents

2 Introduction 14
2.1 Catalyst 15
3 Competitive Assessment 16
3.1 Overview 16
3.2 Global Market Share 16
3.3 Marketed Products 17
3.3.1 Aachen Resonance 17
3.3.2 Abbott Vascular 19
3.3.3 Acandis 21
3.3.4 B. Braun 23
3.3.5 BALT Extrusion 24
3.3.6 Blockade Medical 30
3.3.7 Boston Scientific Corporation 31
3.3.8 Contego Medical 33
3.3.9 Cook Medical 33
3.3.10 Covidien 34
3.3.11 Gardia Medical 41
3.3.12 Gore Medical 42
3.3.13 InspireMD 44
3.3.14 ITGI Medical 45
3.3.15 Johnson and Johnson 46
3.3.16 Medikit 52
3.3.17 Medtronic 54
3.3.18 Merlin MD 56
3.3.19 MicroPort Scientific Corporation 58
3.3.20 Minvasys 60
3.3.21 Neuravi 61
3.3.22 Optimed 62
3.3.23 Penumbra 63
3.3.24 Phenox GmbH 67
3.3.25 Reverse Medical 69
3.3.26 Sequent Medical 71
3.3.27 Stryker Neurovascular Intervention 73
3.3.28 Terumo Corporation 78
3.3.29 Valor Medical 86
4 Pipeline Assessment 88
4.1 Overview 88
4.2 Pipeline by Stage of Development 89
4.3 Product Profiles 91
4.3.1 Aneurysm Occlusion Saddle 91
4.3.2 Ballstent Microcatheter 91
4.3.3 Blood Clot Removing Device 92
4.3.4 EKOS' EkoSonic Small Vessel Endovascular System 92
4.3.5 Flow-Diverting Thin-Film Nitinol Covered Stent 93
4.3.6 Ischemic Stroke System 93
4.3.7 Janjua Aneurysm Net 94
4.3.8 Multilayer Aneurysm Repair System 95
4.3.9 NAVIMAX 96
4.3.10 Palmaz Scientific Stents 97
4.3.11 Silk Road System 98
4.3.12 Transcranial Thrombectomy Catheter 99
5 Current and Future Players 100
5.1 Overview 100
5.2 Trends in Corporate Strategy 100
5.3 Company Profiles 102
5.3.1 BALT Extrusion 102
5.3.2 Covidien 105
5.3.3 Johnson and Johnson 108
5.3.4 Penumbra 113
5.3.5 Stryker Corporation 116
5.3.6 Terumo Corporation 118
5.3.7 Abbott Vascular 122
5.3.8 Boston Scientific Corporation 124
5.3.9 Cook Medical 126
5.3.10 Gore Medical 128
5.3.11 Medtronic 130
5.3.12 Aachen Resonance 133
5.3.13 Acandis 135
5.3.14 B. Braun 137
5.3.15 Blockade Medical 139
5.3.16 Contego Medical 140
5.3.17 Gardia Medical 141
5.3.18 InspireMD 143
5.3.19 ITGI Medical 145
5.3.20 Medikit 146
5.3.21 Merlin MD 147
5.3.22 MicroPort Scientific Corporation 149
5.3.23 Minvasys 150
5.3.24 Neuravi 152
5.3.25 Optimed 153
5.3.26 Phenox GmBH 155
5.3.27 Reverse Medical 156
5.3.28 Sequent Medical 158
5.3.29 Valor Medical 159
5.3.30 Other Companies 162
6 Appendix 164
6.1 Bibliography 164
6.2 Abbreviations 175
6.3 Report Methodology 178
6.3.1 Overview 178
6.3.2 Coverage 178
6.3.3 Secondary Research 178
6.4 Physicians and Specialists Included in this Study 180
6.4.1 Vivek Gupta, MD 180
6.4.2 Zsolt Kulscár, MD, PhD 180
6.4.3 Salvatore Mangiafico, MD 180
6.4.4 Thanh Nguyen, MD, FRCPc 180
6.4.5 Eduardo Wajnberg, MD 180
6.4.6 Phil White, MD 181
6.4.7 Osama O Zaidat, MD, MS, FAAN, FAHA 181
6.5 Primary Research 182
6.5.1 Primary Research - Key Opinion Leader Interviews 182
6.5.2 Expert Panel Validation 182
6.6 Forecasting Methodology 183
6.7 About the Authors 185
6.7.1 Analysts 185
6.7.2 Global Head of Healthcare 186
6.8 About MediPoint 187
6.9 About GlobalData 187
6.10 Disclaimer 187

1.1 List of Tables

Table 1: Aachen Resonance Neurovascular Intervention Marketed Product 17
Table 2: Aachen Resonance Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 19
Table 3: Abbott Vascular Neurovascular Intervention Marketed Products 20
Table 4: Abbott Vascular Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 21
Table 5: Acandis Neurovascular Intervention Marketed Products 22
Table 6: Acandis Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 23
Table 7: B. Braun Neurovascular Intervention Marketed Product 24
Table 8: B. Braun Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 24
Table 9: BALT Extrusion Neurovascular Intervention Marketed Products 26
Table 10: BALT Extrusion Neurovascular Intervention Marketed Access Products 28
Table 11: BALT Extrusion Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 29
Table 12: Blockade Medical Neurovascular Intervention Marketed Product 30
Table 13: Blockade Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 31
Table 14: Boston Scientific Neurovascular Intervention Marketed Products 32
Table 15: Boston Scientific Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 32
Table 16: Contego Medical Neurovascular Intervention Marketed Product 33
Table 17: Contego Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 33
Table 18: Cook Medical Neurovascular Intervention Marketed Products 34
Table 19: Cook Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 34
Table 20: Covidien Neurovascular Interventional Marketed Products 36
Table 21: Covidien Neurovascular Intervention Marketed Access Products 39
Table 22: Covidien Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 40
Table 23: Gardia Medical Neurovascular Intervention Marketed Product 41
Table 24: Gardia Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 42
Table 25: Gore Medical Neurovascular Intervention Marketed Products 43
Table 26: Gore Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 43
Table 27: InspireMD Neurovascular Intervention Marketed Product 44
Table 28: InspireMD Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 44
Table 29: ITGI Medical Neurovascular Intervention Marketed Product 45
Table 30: ITGI Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 46
Table 31: Codman Neurovascular Marketed Embolization Products 47
Table 32: Codman Neurovascular Marketed Mechanical Thrombectomy and Access Products 49
Table 33: Codman Neurovascular's (Codman and Shurtleff) Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 50
Table 34: Cordis Corporation Marketed Neurointerventional Products 51
Table 35: Cordis Corporation Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 52
Table 36: Medikit Neurovascular Intervention Marketed Products 53
Table 37: Medikit Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 54
Table 38: Medtronic Neurovascular Intervention Marketed Products 55
Table 39: Medtronic Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 56
Table 40: Merlin MD Neurovascular Intervention Marketed Product 57
Table 41: Merlin MD Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 58
Table 42: MicroPort Scientific Corporation Neurovascular Intervention Marketed Products 59
Table 43: MicroPort Scientific Corporation Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 60
Table 44: Minvasys Neurovascular Intervention Marketed Product 61
Table 45: Minvasys Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 61
Table 46: Neuravi Neurovascular Intervention Marketed Product 62
Table 47: Neuravi Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 62
Table 48: Optimed Neurovascular Intervention Marketed Products 63
Table 49: Optimed Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 63
Table 50: Penumbra Neurovascular Intervention Marketed Products 64
Table 51: Penumbra Marketed Neurovascular Access Products 66
Table 52: Penumbra Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 67
Table 53: Phenox GmbH Neurovascular Intervention Marketed Products 68
Table 54: Phenox GmbH Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 69
Table 55: Reverse Medical Neurovascular Intervention Marketed Products 70
Table 56: Reverse Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 71
Table 57: Sequent Medical Neurovascular Intervention Marketed Products 72
Table 58: Sequent Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 73
Table 59: Stryker Neurovascular Intervention Marketed Products 75
Table 60: Stryker Neurovascular Intervention Marketed Mechanical Thrombectomy and Access Products 76
Table 61: Stryker Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 78
Table 62: Terumo Europe N.V. and Terumo Interventional Systems Marketed Neurointerventional Products 80
Table 63: Terumo Corporation Neurovascular Product Portfolio SWOT Analysis, 2014 81
Table 64: MicroVention Neurovascular Intervention Marketed Products 83
Table 65: MicroVention Marketed Neurovascular Access Products 85
Table 66: MicroVention Neurovascular Product Portfolio SWOT Analysis, 2014 86
Table 67: Valor Medical Neurovascular Intervention Marketed Products 87
Table 68: Valor Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 87
Table 69: Global Neurovascular Interventions Pipeline Products 90
Table 70: Aneurysm Occlusion Saddle SWOT Analysis, 2014 91
Table 71: EKOS EkoSonic SV System SWOT Analysis, 2014 92
Table 72: Flow-Diverting Thin-Film Nitinol Covered Stent SWOT Analysis, 2014 93
Table 73: Janjua Aneurysm Net SWOT Analysis, 2014 94
Table 74: Multilayer Aneurysm Repair System SWOT Analysis, 2014 95
Table 75: NAVIMAX SWOT Analysis, 2014 96
Table 76: Palmaz Scientific Stents SWOT Analysis, 2014 97
Table 77: Silk Road System SWOT Analysis, 2014 98
Table 78: BALT Extrusion Company Profile 103
Table 79: BALT Extrusion Neurovascular Intervention Marketed Products 104
Table 80: BALT Extrusion SWOT Analysis, 2014 105
Table 81: Covidien Company Profile 106
Table 82: Covidien Neurovascular Intervention Marketed Products 107
Table 83: Covidien SWOT Analysis, 2014 108
Table 84: Codman and Shurtleff Company Profile 109
Table 85: Codman and Shurtleff Neurovascular Intervention Marketed Products 110
Table 86: Codman and Shurtleff SWOT Analysis, 2014 111
Table 87: Cordis Corporation Company Profile 111
Table 88: Cordis Corporation Neurovascular Intervention Marketed Products 112
Table 89: Cordis Corporation SWOT Analysis, 2014 113
Table 90: Penumbra Company Profile 113
Table 91: Penumbra Neurovascular Intervention Marketed Products 115
Table 92: Penumbra SWOT Analysis, 2014 115
Table 93: Stryker Corporation Company Profile 116
Table 94: Stryker Corporation Neurovascular Intervention Marketed Products 117
Table 95: Stryker Corporation SWOT Analysis, 2014 118
Table 96: Terumo Corporation Company Profile 119
Table 97: Terumo Europe N.V. and Terumo Interventional Systems Neurovascular Intervention Marketed Products 120
Table 98: MicroVention Neurovascular Intervention Marketed Products 121
Table 99: Terumo Corporation SWOT Analysis, 2014 122
Table 100: Abbott Vascular Company Profile 122
Table 101: Abbott Vascular Neurovascular Intervention Marketed Products 123
Table 102: Abbott Vascular SWOT Analysis, 2014 124
Table 103: Boston Scientific Corporation Company Profile 125
Table 104: Boston Scientific Neurovascular Intervention Marketed Products 125
Table 105: Boston Scientific Corporation SWOT Analysis, 2014 126
Table 106: Cook Medical Company Profile 126
Table 107: Cook Medical Neurovascular Intervention Marketed Products 127
Table 108: Cook Medical SWOT Analysis, 2014 128
Table 109: Gore Medical Company Profile 129
Table 110: Gore Medical Neurovascular Intervention Marketed Products 129
Table 111: Gore Medical SWOT Analysis, 2014 130
Table 112: Medtronic Company Profile 131
Table 113: Medtronic Neurovascular Intervention Marketed Products 132
Table 114: Medtronic SWOT Analysis, 2014 132
Table 115: Aachen Resonance Company Profile 133
Table 116: Aachen Resonance Neurovascular Intervention Marketed Product 134
Table 117: Aachen Resonance SWOT Analysis, 2014 134
Table 118: Acandis Company Profile 135
Table 119: Acandis Neurovascular Intervention Marketed Products 136
Table 120: Acandis SWOT Analysis, 2014 136
Table 121: B. Braun Company Profile 137
Table 122: B. Braun Neurovascular Intervention Marketed Product 138
Table 123: B. Braun SWOT Analysis, 2014 138
Table 124: Blockade Medical Company Profile 139
Table 125: Blockade Medical Neurovascular Intervention Marketed Product 139
Table 126: Blockade Medical SWOT Analysis, 2014 140
Table 127: Contego Medical Company Profile 140
Table 128: Contego Medical Neurovascular Intervention Marketed Product 141
Table 129: Contego Medical SWOT Analysis, 2014 141
Table 130: Gardia Medical Company Profile 142
Table 131: Gardia Medical Neurovascular Intervention Marketed Product 142
Table 132: Gardia Medical SWOT Analysis, 2014 143
Table 133: InspireMD Company Profile 144
Table 134: InspireMD Neurovascular Intervention Marketed Product 144
Table 135: InspireMD SWOT Analysis, 2014 144
Table 136: ITGI Medical Company Profile 145
Table 137: ITGI Medical Neurovascular Intervention Marketed Product 145
Table 138: ITGI Medical SWOT Analysis, 2014 146
Table 139: Medikit Company Profile 146
Table 140: Medikit Neurovascular Intervention Marketed Products 147
Table 141: Medikit SWOT Analysis, 2014 147
Table 142: Merlin MD Company Profile 148
Table 143: Merlin MD Neurovascular Intervention Marketed Product 148
Table 144: Merlin MD SWOT Analysis, 2014 148
Table 145: MicroPort Scientific Corporation Company Profile 149
Table 146: MicroPort Scientific Corporation Neurovascular Intervention Marketed Products 149
Table 147: MicroPort Scientific Corporation SWOT Analysis, 2014 150
Table 148: Minvasys Company Profile 151
Table 149: Minvasys Neurovascular Intervention Marketed Product 151
Table 150: Minvasys SWOT Analysis, 2014 151
Table 151: Neuravi Company Profile 152
Table 152: Neuravi Neurovascular Intervention Marketed Product 152
Table 153: Neuravi SWOT Analysis, 2014 153
Table 154: Optimed Company Profile 154
Table 155: Optimed Neurovascular Intervention Marketed Products 154
Table 156: Optimed SWOT Analysis, 2014 154
Table 157: Phenox GmBH Company Profile 155
Table 158: Phenox GmbH Neurovascular Intervention Marketed Products 156
Table 159: Phenox GmBH SWOT Analysis, 2014 156
Table 160: Reverse Medical Company Profile 157
Table 161: Reverse Medical Neurovascular Intervention Marketed Products 157
Table 162: Reverse Medical SWOT Analysis, 2014 158
Table 163: Sequent Medical Company Profile 158
Table 164: Sequent Medical Neurovascular Intervention Marketed Products 159
Table 165: Sequent Medical SWOT Analysis, 2014 159
Table 166: Valor Medical Company Profile 160
Table 167: Valor Medical Neurovascular Intervention Marketed Products 160
Table 168: Valor Medical SWOT Analysis, 2014 161
Table 169: Other Companies in the Neurovascular Intervention Market, 2014 162

1.2 List of Figures
Figure 1: Global Neurointerventional Market Distribution, 2013 16
Figure 2: Global Neurovascular Interventions Pipeline Products by Stage of Development, 2014 89

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Cardiovascular Surgical Devices: Technologies and Global Markets

Cardiovascular Surgical Devices: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about the trends and developments affecting each type of cardiovascular surgical technology - Analyze trends and opportunities in major regions: North America, Europe, Asia ...

TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.